Long-Term Outcomes of Epilepsy Surgery in Adults and Children
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This book provides a comprehensive, rigorous review of the long-term outcome literature in epilepsy surgery in both adults and children. Each chapter examines the long-term outcome literature in a separate domain; covering seizure control, social, vocational/educational and psychiatric outcomes. Behavior and cognition are also discussed. The clinical predictors of good and bad outcomes in each domain are described and the gaps in current knowledge are highlighted. Separate chapters examine the methodological challenges associated with long-term outcome studies and the special considerations associated with informed consent in this population. Long-Term Outcomes of Epilepsy Surgery in Adults and Children is essential reading for all members of multidisciplinary epilepsy surgery teams, including neurosurgeons, neurologists and neuropsychologists; it will enable these teams to counsel patients and parents who are considering epilepsy surgery as a therapeutic option.¿
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Kristina Malmgren, MD, PhD Sahlgrenska University HospitalGothenburg Sweden and Institute of Neuroscience and PhysiologyDept of Clinical Neuroscience and RehabilitationSahlgrenska Academy at Gothenburg University, Gothenburg Sweden Sallie Baxendale, PhD,
- hardcover
- 288 Seiten
- Erschienen 2015
- Wiley-Blackwell
- Hardcover
- 336 Seiten
- Erschienen 2024
- Mac Keith Press
- Gebunden
- 550 Seiten
- Erschienen 2010
- Springer
- Taschenbuch
- 544 Seiten
- Erschienen 2010
- Cambridge University Press
- hardcover
- 592 Seiten
- Erschienen 2009
- Springer
- hardcover -
- Erschienen 2004
- Novartis Pharma
- Taschenbuch
- 282 Seiten
- Erschienen 2010
- Routledge
- hardcover
- 302 Seiten
- Erschienen 2000
- Futura Publishing Co Inc.,U.S.
- hardcover
- 435 Seiten
- Erschienen 1990
- Springer
- flexibound
- 463 Seiten
- Elsevier, München
- hardcover -
- Erschienen 2004
- Novartis Pharma




